Document 0252 DOCN M9550252 TI Intrinsic activity of human immunodeficiency virus type 1 protease heterologous fusion proteins in mammalian cells. DT 9505 AU Arrigo SJ; Haines JK; Huffman KM; Department of Microbiology and Immunology, Medical University of; South Carolina, Charleston 29425-2230. SO DNA Cell Biol. 1995 Jan;14(1):15-23. Unique Identifier : AIDSLINE MED/95134352 AB We have generated various mammalian expression constructs that produce fusion proteins of human immunodeficiency virus type 1 (HIV-1) protease (PR) with the HIV-1 Nef protein. The expression of these proteins is inducible by the HIV-1 Tat protein. High-level expression of proteolytically active PR was produced from PR imbedded into Nef coding sequences, flanked by PR cleavage sites. The fusion protein was cleaved nearly to completion and did not exhibit the regulated processing that is seen with the virally encoded PR. No cytotoxic effect of PR expression was detected. The self-cleavage of PR could be inhibited by a specific inhibitor of HIV-1 PR (U75875). Elimination of the aminoterminal PR cleavage site did not have a measurable effect on cleavage of the precursor fusion protein. The cleaved fusion proteins appeared to be extremely unstable in the transfected cells. These findings demonstrate the intrinsic activity of HIV-1 PR in mammalian cells, in the context of a heterologous fusion protein. DE Animal Base Sequence Cell Line Gene Expression Regulation, Viral Gene Products, nef/*GENETICS Gene Products, tat/GENETICS Genetic Vectors/GENETICS Human HIV Protease/BIOSYNTHESIS/GENETICS/*METABOLISM HIV Protease Inhibitors/PHARMACOLOGY HIV-1/*METABOLISM Mammals Molecular Sequence Data Protein Processing, Post-Translational/DRUG EFFECTS Recombinant Fusion Proteins/BIOSYNTHESIS/METABOLISM/TOXICITY RNA, Messenger/BIOSYNTHESIS Sequence Deletion/PHYSIOLOGY Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).